Latest News…

Revolutionary autoinjector pushes the limits of high viscosity drug delivery

17th April 2013 – Oval Medical Technologies Ltd (‘Oval’), today have announced that a variety of 1100 cPs solutions (the thickness of motor oil) have been successfully delivered through a 25G thin wall needle, in less than 7 seconds, using their revolutionary autoinjector. Oval is a cutting-edge autoinjector company based in Cambridge UK. Their autoinjector [...]

Read full story • Comments are closed

Oval Medical receives ISO 13485:2012 certification for medical device development

21st February 2013 – Oval Medical Technologies Ltd (‘Oval’), the privately held autoinjector development company, today announced that is has been awarded BS EN ISO 13485:2012 certification. ISO 13485 is a quality standard certifying that the company has a comprehensive management system in place for the design, development and manufacture of drug delivery devices. This [...]

Read full story • Comments are closed

Oval Medical signs a technology assessment contract with a pharmaceutical partner

February 12th, 2013 – Oval Medical Technologies Ltd.(“Oval”), announces that it has signed a further technology assessment contract with a pharmaceutical partner. The drug under investigation is for the treatment of severe infections in patients with chronic lung disease and is expected to be self-injected in a clinical or home setting. The agreement includes a [...]

Read full story • Comments are closed

Oval Medical Technologies signs key agreement with leading global pharmaceutical company

May 14th, 2012 – Oval Medical Technologies Ltd. (“Oval”), the company developing the next generation of autoinjectors, today announced that they have entered into an agreement with a top ten global pharmaceutical company to evaluate one of their leading prescription drugs in Oval’s novel autoinjector technology. Under the terms of Agreement, the pharmaceutical company has [...]

Read full story • Comments are closed